1479 related articles for article (PubMed ID: 38763973)
1. Tumor biomarkers for diagnosis, prognosis and targeted therapy.
Zhou Y; Tao L; Qiu J; Xu J; Yang X; Zhang Y; Tian X; Guan X; Cen X; Zhao Y
Signal Transduct Target Ther; 2024 May; 9(1):132. PubMed ID: 38763973
[TBL] [Abstract][Full Text] [Related]
2. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies.
Umelo IA; Costanza B; Castronovo V
Cancer Metastasis Rev; 2018 Mar; 37(1):125-145. PubMed ID: 29392535
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy in cancer.
Tsimberidou AM
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
[TBL] [Abstract][Full Text] [Related]
4. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
Front Immunol; 2020; 11():1280. PubMed ID: 32849491
[TBL] [Abstract][Full Text] [Related]
5. Cancer molecular markers: A guide to cancer detection and management.
Nair M; Sandhu SS; Sharma AK
Semin Cancer Biol; 2018 Oct; 52(Pt 1):39-55. PubMed ID: 29428478
[TBL] [Abstract][Full Text] [Related]
6. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
Kamel HFM; Al-Amodi HSAB
Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
[TBL] [Abstract][Full Text] [Related]
7. Toward Personalized Cancer Treatment: From Diagnostics to Therapy Monitoring in Miniaturized Electrohydrodynamic Systems.
Khondakar KR; Dey S; Wuethrich A; Sina AA; Trau M
Acc Chem Res; 2019 Aug; 52(8):2113-2123. PubMed ID: 31293158
[TBL] [Abstract][Full Text] [Related]
8. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetics and Cytogenomics Evaluation in Cancer.
Ribeiro IP; Melo JB; Carreira IM
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547595
[TBL] [Abstract][Full Text] [Related]
10. [New directions in biomarker research, drug development and personalized medicine].
Németh G; Jelinek I
Magy Onkol; 2013 Mar; 57(1):5-10. PubMed ID: 23573515
[TBL] [Abstract][Full Text] [Related]
11. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
12. Unlocking the potential of oncology biomarkers: advancements in clinical theranostics.
Dubey AK; Kaur I; Madaan R; Raheja S; Bala R; Garg M; Kumar S; Lather V; Mittal V; Pandita D; Gundamaraju R; Singla RK; Sharma R
Drug Metab Pers Ther; 2024 Mar; 39(1):5-20. PubMed ID: 38469723
[TBL] [Abstract][Full Text] [Related]
13. Oncoproteomics: Current status and future opportunities.
He Y; Mohamedali A; Huang C; Baker MS; Nice EC
Clin Chim Acta; 2019 Aug; 495():611-624. PubMed ID: 31176645
[TBL] [Abstract][Full Text] [Related]
14. Cancer Biomarker Discovery for Precision Medicine: New Progress.
Zou J; Wang E
Curr Med Chem; 2019; 26(42):7655-7671. PubMed ID: 30027846
[TBL] [Abstract][Full Text] [Related]
15. Metastatic biomarker discovery through proteomics.
Brinton LT; Brentnall TA; Smith JA; Kelly KA
Cancer Genomics Proteomics; 2012 Nov; 9(6):345-55. PubMed ID: 23162074
[TBL] [Abstract][Full Text] [Related]
16. Oncoproteomics: Trials and tribulations.
Zhou L; Li Q; Wang J; Huang C; Nice EC
Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
[TBL] [Abstract][Full Text] [Related]
17. Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine.
Supplitt S; Karpinski P; Sasiadek M; Laczmanska I
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572595
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
Cheng F; Su L; Qian C
Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
[TBL] [Abstract][Full Text] [Related]
19. Germline Genetics in Immuno-oncology: From Genome-Wide to Targeted Biomarker Strategies.
Kirchhoff T; Ferguson R
Methods Mol Biol; 2020; 2055():93-117. PubMed ID: 31502148
[TBL] [Abstract][Full Text] [Related]
20. Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.
Passaro A; Al Bakir M; Hamilton EG; Diehn M; André F; Roy-Chowdhuri S; Mountzios G; Wistuba II; Swanton C; Peters S
Cell; 2024 Mar; 187(7):1617-1635. PubMed ID: 38552610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
